CA1012965A - Heptapeptides having gastrin activity - Google Patents

Heptapeptides having gastrin activity

Info

Publication number
CA1012965A
CA1012965A CA186,203A CA186203A CA1012965A CA 1012965 A CA1012965 A CA 1012965A CA 186203 A CA186203 A CA 186203A CA 1012965 A CA1012965 A CA 1012965A
Authority
CA
Canada
Prior art keywords
heptapeptides
gastrin activity
gastrin
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA186,203A
Other languages
English (en)
Inventor
Rudolf Schleyerbach
Rolf Geiger
Hans Wissmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of CA1012965A publication Critical patent/CA1012965A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA186,203A 1972-11-17 1973-11-16 Heptapeptides having gastrin activity Expired CA1012965A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2256445A DE2256445C3 (de) 1972-11-17 1972-11-17 Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
CA1012965A true CA1012965A (en) 1977-06-28

Family

ID=5862026

Family Applications (1)

Application Number Title Priority Date Filing Date
CA186,203A Expired CA1012965A (en) 1972-11-17 1973-11-16 Heptapeptides having gastrin activity

Country Status (15)

Country Link
US (1) US3931141A (fr)
JP (1) JPS5724778B2 (fr)
AT (1) AT329203B (fr)
BE (1) BE807501A (fr)
CA (1) CA1012965A (fr)
CH (1) CH587802A5 (fr)
DE (1) DE2256445C3 (fr)
DK (1) DK147733C (fr)
ES (1) ES420458A1 (fr)
FR (1) FR2206948B1 (fr)
GB (1) GB1429700A (fr)
IL (1) IL43632A (fr)
NL (1) NL181331C (fr)
SE (1) SE394426B (fr)
ZA (1) ZA738785B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2628006C2 (de) * 1976-06-23 1986-11-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
DE3061586D1 (en) * 1979-04-30 1983-02-17 Max Planck Gesellschaft Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them
US4530836A (en) * 1983-05-31 1985-07-23 Amano Pharmaceutical Co., Ltd. Peptide
JPS6194392A (ja) * 1984-10-15 1986-05-13 富士通テン株式会社 基板接続方法
IT1204430B (it) * 1986-01-10 1989-03-01 Alfio Bertolini Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
US5023077A (en) * 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
DK0380230T3 (da) * 1989-01-24 1995-01-16 Aphton Corp Immunogene sammensætninger mod gastrin-peptider
US6861510B1 (en) 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
HUP0002760A3 (en) * 1997-05-12 2003-03-28 Aphton Corp Woodland Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
PT1077721E (pt) * 1998-05-15 2007-06-21 Receptor Biologix Inc Prevenção e tratamento da hipergastrinemia.
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
WO2002076499A2 (fr) 2001-03-23 2002-10-03 Aphton Corporation Traitement combine du cancer du pancreas
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
CN1781023A (zh) 2003-03-28 2006-05-31 埃弗顿有限公司 胃泌素激素免疫测定
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2005095459A2 (fr) * 2004-03-29 2005-10-13 Receptor Biologix, Inc. Anticorps monoclonaux de l'hormone gastrine
JP2008513536A (ja) * 2004-09-22 2008-05-01 レセプター バイオロジックス インコーポレイテッド プロガストリンに対するモノクローナル抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042487A (en) * 1964-06-25 1966-09-14 Ici Ltd Polypeptide derivatives
GB1224576A (en) * 1968-08-24 1971-03-10 Tanabe Seiyaku Co Novel tetrapeptide amides and the preparation thereof

Also Published As

Publication number Publication date
FR2206948A1 (fr) 1974-06-14
JPS5724778B2 (fr) 1982-05-26
AT329203B (de) 1976-04-26
ATA964673A (de) 1975-07-15
CH587802A5 (fr) 1977-05-13
NL181331C (nl) 1987-08-03
DE2256445B2 (de) 1980-11-20
AU6249773A (en) 1975-05-15
GB1429700A (en) 1976-03-24
DE2256445A1 (de) 1974-05-22
NL181331B (nl) 1987-03-02
JPS504067A (fr) 1975-01-16
SE394426B (sv) 1977-06-27
IL43632A (en) 1976-09-30
DK147733B (da) 1984-11-26
ES420458A1 (es) 1976-04-01
BE807501A (fr) 1974-05-20
DK147733C (da) 1985-06-17
NL7315444A (fr) 1974-05-21
FR2206948B1 (fr) 1978-01-13
US3931141A (en) 1976-01-06
DE2256445C3 (de) 1981-11-05
ZA738785B (en) 1974-10-30
IL43632A0 (en) 1974-03-14

Similar Documents

Publication Publication Date Title
CA982859A (en) Bladeholders
AU462348B2 (en) Saf-t-jet
CA1012965A (en) Heptapeptides having gastrin activity
AU454372B2 (en) Childsafe actuator-overcap
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
CA986359A (en) Projectile-case connection
CA962268A (en) Cycloalkyllactamimides
AU469111B2 (en) New 2-benzoyl-3-amino-pyridines
AU443963B2 (en) New nitroimidazolyl-triazolo-pyridazines
CA999299A (en) 2-amino-4h-pyrane
CA984389A (en) Dibenzo-triazolo-azepines,-diazepines,-oxazepines and -thiazepines
AU5342873A (en) Pyronorifamycins
AU4575372A (en) 2-acyl-5-nitrothiazoles
AU480094B2 (en) Peptides having gastrin activity
KR780000099B1 (en) Novel heptapeptides having gastrin activity
AU478110B2 (en) Functional elements
CA916164A (en) N-cyanacetyl o-phenylenediamines
AU478476B2 (en) Improved rollerskate
CA909239A (en) Hydroxyarylpolymethylenesulfonium zwitterions
CA902644A (en) Dihalophenyl-bis-(hydroxyarylethers)
AU470823B2 (en) New aminoisoquinolines
CA893406A (en) Double deck-bed arrangement
AU469398B2 (en) N-benzyl-tetrahydropyridines
CA1018980A (en) 5-aroyl-2-(tetrazol-2-yimethyl)-pyrroles
CA892609A (en) Diazepinoindoles